PMC full text:
Published online 2003 Dec 1. doi: 10.1373/clinchem.2003.024125
Table 1.
Patients | Plasma SARS-CoV concentration, copies/mL | ||||
---|---|---|---|---|---|
Day 1 | Day 7 | Day 14 | |||
1 | 298 | Undetectable | 173 | ||
2 | 231 | 363 | Undetectable | ||
3 | Undetectable | Undetectable | Undetectable | ||
4 | Undetectable | Undetectable | 100 | ||
5 | 239 | 170 | Undetectable | ||
6 | Undetectable | Undetectable | Undetectable | ||
7 | Undetectable | 8565 | Undetectable | ||
8 | 230 | 819 | Undetectable | ||
9 | 125 | 413 | Undetectable | ||
10 | Undetectable | Undetectable | Undetectable | ||
11 | 404 | 84 | Undetectable | ||
12 | Undetectable | Undetectable | 153 | ||
Detection rate | 50% | 50% | 25% |
1The detection limit of the assay is 74 copies/mL. Day 1, day 7, and day 14 denote the days after fever onset. The nucleocapsid RT-PCR system has a higher detection sensitivity (see text).